title: Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studies.
abstract: Here the authors discuss evidence in human and animal models supporting two opposing views regarding the pathogenesis of human immunodeficiency virus (HIV) in the central nervous system (CNS): (1) HIV infection in the CNS is a compartmentalized infection, with the virus-infected macrophages entering the CNS early, infecting resident microglia and astrocytes, and achieving a state of latency with evolution toward a fulminant CNS infection late in the course of disease; or alternatively, (2) events in the periphery lead to altered monocyte/macrophage (MPhi) homeostasis, with increased CNS invasion of infected and/or uninfected MPhis. Here the authors have reevaluated evidence presented in the favor of the latter model, with a discussion of phenotypic characteristics distinguishing normal resident microglia with those accumulating in HIV encephalitis (HIVE). CD163 is normally expressed by perivascular MPhi s but not resident microglia in normal CNS of humans and rhesus macaques. In agreement with other studies, the authors demonstrate expression of CD163 by brain MPhi s in HIVE and simian immunodeficiency virus encephalitis (SIVE). CNS tissues from HIV-sero positive individuals with HIVE or HIV-associated progressive multifocal leukoencephalopathy (PML) were also examined. In HIVE, the authors further demonstrate colocalization of CD163 and CD16 (Fcgamma III recptor) gene expression, the latter marker associated with HIV infection of monocyte in vivo and permissivity of infection. Indeed, CD163(+) MPhis and microglia are often productively infected in HIVE CNS. In SIV infected rhesus macaques, CD163(+) cells accumulate perivascularly, within nodular lesions and the parenchyma in animals with encephalitis. Likewise, parenchymal microglia and perivascular MPhi s are CD163(+) in HIVE. In contrast to HIVE, CD163(+)perivascular and parenchymal MPhi s in HIV-associated PML were only associated with areas of demyelinating lesions. Interestingly, SIV-infected rhesus macaques whose viral burden was predominantly at 1 x 10(6) copies/ml or greater developed encephalitis. To further investigate the relationship between CD163(+)/CD16(+) MPhis/microglia in the CNS and altered homeostasis in the periphery, the authors performed flow-cytometric analyses of peripheral blood mononuclear cells (PBMCs) from SIV-infected rhesus macaques. The results demonstrate an increase in the percent frequency of CD163(+)/CD16(+) monocytes in animals with detectable virus that correlated significantly with increased viral burden and CD4(+) T-cell decline. These results suggest the importance of this monocyte subset in HIV/SIV CNS disease, and also in the immune pathogenesis of lentiviral infection. The authors further discuss the potential role of CD163(+)/CD16(+) monocyte/MPhi subset expansion, altered myeloid homeostasis, and potential consequences for immune polarization and suppression. The results and discussion here suggest new avenues for the development of acquired immunodeficiency syndrome (AIDS) therapeutics and vaccine design.
authors.affiliation: Department of Neuroscience, Center for Neurovirology, Temple University School of Medicine, Philadelphia, Pennsylvania 19122, USA.
authors.forename: Tracy
authors.initials: T
authors.lastname: Fischer-Smith
authors.forename: Christie
authors.initials: C
authors.lastname: Bell
authors.forename: Sidney
authors.initials: S
authors.lastname: Croul
authors.forename: Mark
authors.initials: M
authors.lastname: Lewis
authors.forename: Jay
authors.initials: J
authors.lastname: Rappaport
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000503:physiopathology*; D000818:Animals; D002490:Central Nervous System / Q000503:physiopathology / Q000821:virology; D018792:Encephalitis, Viral / Q000209:etiology* / Q000503:physiopathology*; D006678:HIV / Q000502:physiology; D006801:Humans; D008253:Macaca mulatta; D008264:Macrophages / Q000378:metabolism* / Q000821:virology; D009000:Monocytes / Q000378:metabolism* / Q000473:pathology; D016097:Simian Acquired Immunodeficiency Syndrome / Q000150:complications / Q000503:physiopathology / Q000821:virology; D015302:Simian Immunodeficiency Virus / Q000502:physiology
references.citation: J Neuropathol Exp Neurol. 2007 Jan;66(1):26-34
references.pmid: 17204934
references.citation: APMIS. 1989 Jan;97(1):79-90
references.pmid: 2914109
references.citation: J Leukoc Biol. 2000 Jan;67(1):97-103
references.pmid: 10648003
references.citation: J Immunol. 1995 May 15;154(10):5528-35
references.pmid: 7537309
references.citation: Immunobiology. 2005;210(2-4):153-60
references.pmid: 16164022
references.citation: J Neuropathol Exp Neurol. 1993 Sep;52(5):460-70
references.pmid: 8103085
references.citation: Am J Clin Pathol. 2004 Nov;122(5):794-801
references.pmid: 15491976
references.citation: Nat Rev Immunol. 2005 Jan;5(1):69-81
references.pmid: 15630430
references.citation: Immunobiology. 2006;211(6-8):487-501
references.pmid: 16920488
references.citation: Immunobiology. 2006;211(6-8):473-86
references.pmid: 16920487
references.citation: J Immunol. 1995 May 1;154(9):4309-21
references.pmid: 7722289
references.citation: Neurology. 2001 Jan 23;56(2):257-60
references.pmid: 11160967
references.citation: Neurology. 1993 Nov;43(11):2245-52
references.pmid: 8232937
references.citation: J Neuropathol Exp Neurol. 1994 Sep;53(5):492-501
references.pmid: 8083690
references.citation: Immunobiology. 2005;210(2-4):77-86
references.pmid: 16164014
references.citation: Am J Surg Pathol. 2005 May;29(5):617-24
references.pmid: 15832085
references.citation: J Immunol. 1998 Aug 15;161(4):1883-90
references.pmid: 9712057
references.citation: Lancet. 1997 Mar 8;349(9053):692-5
references.pmid: 9078201
references.citation: J Neurovirol. 2001 Dec;7(6):528-41
references.pmid: 11704885
references.citation: Am J Pathol. 2004 Jun;164(6):2089-99
references.pmid: 15161643
references.citation: Nephrol Dial Transplant. 2000 May;15(5):574-8
references.pmid: 10809793
references.citation: Virology. 1999 Aug 1;260(2):295-307
references.pmid: 10417264
references.citation: N Engl J Med. 2003 Jan 9;348(2):138-50
references.pmid: 12519925
references.citation: J Histochem Cytochem. 2006 Jul;54(7):763-71
references.pmid: 16517975
references.citation: Am J Pathol. 2002 Aug;161(2):575-85
references.pmid: 12163382
references.citation: Eur J Immunol. 1996 Nov;26(11):2758-63
references.pmid: 8921966
references.citation: J Neuropathol Exp Neurol. 2004 Dec;63(12):1255-64
references.pmid: 15624762
references.citation: J Exp Med. 2001 Apr 16;193(8):905-15
references.pmid: 11304551
references.citation: J Virol. 2005 Feb;79(3):1772-88
references.pmid: 15650202
references.citation: J Infect Dis. 2002 Oct 1;186(7):905-13
references.pmid: 12232830
references.citation: J Exp Med. 1993 Apr 1;177(4):1145-52
references.pmid: 8459208
references.citation: J Neurosci Res. 1989 Jan;22(1):103-6
references.pmid: 2926837
references.citation: Neuropathol Appl Neurobiol. 2001 Aug;27(4):326-35
references.pmid: 11532163
references.citation: Expert Rev Mol Med. 2005 Dec 02;7(27):1-26
references.pmid: 16321172
references.citation: AIDS. 2000 Sep 8;14(13):1949-54
references.pmid: 10997399
references.citation: Glia. 2005 Sep;51(4):297-305
references.pmid: 15846794
references.citation: J Neurovirol. 2005 Apr;11(2):219-24
references.pmid: 16036800
references.citation: J Neuropathol Exp Neurol. 1992 Sep;51(5):538-49
references.pmid: 1517774
references.citation: J Infect Dis. 2007 Jul 1;196(1):38-42
references.pmid: 17538881
references.citation: J Neurovirol. 2000 May;6 Suppl 1:S70-81
references.pmid: 10871768
references.citation: Folia Neuropathol. 2004;42 Suppl B:39-58
references.pmid: 16903141
references.citation: Nature. 2001 Apr 19;410(6831):988-94
references.pmid: 11309629
references.citation: Am J Pathol. 2004 Feb;164(2):355-62
references.pmid: 14742241
references.citation: J Virol. 1997 Feb;71(2):1608-20
references.pmid: 8995688
references.citation: Ann Neurol. 1995 Nov;38(5):755-62
references.pmid: 7486867
references.citation: AIDS Res Hum Retroviruses. 1987;3(4):363-73
references.pmid: 3447627
references.citation: Arch Neurol. 2007 Jan;64(1):97-102
references.pmid: 17210815
references.citation: Ann Neurol. 1987 May;21(5):490-6
references.pmid: 3296948
references.citation: Hum Pathol. 1991 Jul;22(7):700-10
references.pmid: 2071114
references.citation: Clin Infect Dis. 2002 Jul 1;35(1):82-3
references.pmid: 12060879
references.citation: Annu Rev Immunol. 1990;8:169-94
references.pmid: 2188662
references.citation: J Neuroimmunol. 2004 Dec;157(1-2):99-110
references.pmid: 15579286
references.citation: J Clin Psychiatry. 2006 Nov;67(11):1784-800
references.pmid: 17196061
references.citation: Science. 1988 Jan 15;239(4837):290-2
references.pmid: 3276004
references.citation: Neurology. 2001 Feb 13;56(3):355-61
references.pmid: 11171901
references.citation: Am J Pathol. 2006 Mar;168(3):822-34
references.pmid: 16507898
references.citation: J Immunol. 2007 May 15;178(10):6581-9
references.pmid: 17475889
references.citation: AIDS Patient Care STDS. 2005 Aug;19(8):486-94
references.pmid: 16124842
references.citation: J Neurovirol. 2005 Apr;11(2):180-9
references.pmid: 16036796
references.citation: Clin Exp Immunol. 2005 Dec;142(3):481-9
references.pmid: 16297160
references.citation: Nature. 2001 Jan 11;409(6817):198-201
references.pmid: 11196644
references.citation: J Neuroimmunol. 1998 Apr 15;84(2):238-49
references.pmid: 9628469
references.citation: Cytokine. 2000 Sep;12(9):1312-21
references.pmid: 10975989